According to Verona Pharma's latest financial reports the company's total liabilities are $58.84 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $58.84 M | 102.89% |
2022-12-31 | $29 M | -24.83% |
2021-12-31 | $38.58 M | 99.37% |
2020-12-31 | $19.35 M | 9.37% |
2019-12-31 | $17.69 M | -3.02% |
2018-12-31 | $18.24 M | 3.8% |
2017-12-31 | $17.57 M | -1.18% |
2016-12-31 | $17.78 M | 236.63% |
2015-12-31 | $5.28 M | 315.87% |
2014-12-31 | $1.27 M | -4.54% |
2013-12-31 | $1.33 M | 155.65% |
2012-12-31 | $0.52 M | 38.56% |
2011-12-31 | $0.37 M | -23.45% |
2010-12-31 | $0.49 M | -34.64% |
2009-12-31 | $0.75 M | 316.55% |
2008-12-31 | $0.18 M | -70.85% |
2007-12-31 | $0.61 M | 143.53% |
2006-12-31 | $0.25 M | 615.49% |
2005-12-31 | $0.03 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $3.14 M | -94.65% | Bahamas |
NRC Health
NRC | $73.48 M | 24.88% | ๐บ๐ธ USA |